Skip to main content
Premium Trial:

Request an Annual Quote

Enigma Diagnostics Opens US Office

NEW YORK (GenomeWeb News) – UK-based molecular diagnostics firm Enigma Diagnostics has opened up its US headquarters in San Diego, the firm said yesterday.

The firm has hired Jorge Garces to serve as president and CEO of the US operations, with Greg Hamilton serving as COO and CFO. Garces was most recently VP of R&D and site operations manager for Hologic. Hamilton was VP of operations, planning, and analysis for Hologic's business unit focus on women's healthcare products. He also previously served as VP of finance and operations at Third Wave Technologies, which was acquired for $582 million by Hologic in 2008.

Engima said in a statement that the US headquarters "will expand rapidly with a recruitment programme planned for assay development, R&D, and commercial activities."

Enigma is developing a rapid, point-of-care, molecular diagnostics instrument platform and assays for the clinical and applied markets.

The firm, which is currently based in Porton Down, UK, but recently opened an office in Oxford, also noted that it has hired new executives for its European operations. Nick Williams has joined as CFO Europe, and Darren Hall has joined as COO Europe. Williams has held senior finance roles at Calyx, Truflo International, and Biocompatibles. Hall has worked for Graseby, Smiths Industries, and Biocompatibles.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.